These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29549186)

  • 61. Clostridium difficile infection: A critical analysis of the guidance.
    Aziz AM
    Br J Nurs; 2009 Nov 26-Dec 9; 18(21):1328-32. PubMed ID: 20081684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Key Advantages of a Targeted Incident Reporting System for Severe and Critical Clostridium difficile Infection Incidents.
    Mahamed H; Lemieux C; Hota S
    Healthc Q; 2017; 19(4):44-46. PubMed ID: 28130951
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clostridium difficile control measures: current and future methods for prevention.
    Mejia-Chew C; Dubberke ER
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):121-131. PubMed ID: 29353504
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antimicrobial stewardship and Clostridium difficile-associated diarrhea.
    Piacenti FJ; Leuthner KD
    J Pharm Pract; 2013 Oct; 26(5):506-13. PubMed ID: 23946208
    [TBL] [Abstract][Full Text] [Related]  

  • 65. C. difficile: will lessons be learned?
    Erban J
    CMAJ; 2005 Apr; 172(9):1161. PubMed ID: 15851697
    [No Abstract]   [Full Text] [Related]  

  • 66. Prevention of Infection Due to Clostridium difficile.
    Cooper CC; Jump RL; Chopra T
    Infect Dis Clin North Am; 2016 Dec; 30(4):999-1012. PubMed ID: 27660089
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimizing testing for Clostridium difficile infection: A quality improvement project.
    Sperling K; Priddy A; Suntharam N; Feuerhake T
    Am J Infect Control; 2019 Mar; 47(3):340-342. PubMed ID: 30420098
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis.
    Feazel LM; Malhotra A; Perencevich EN; Kaboli P; Diekema DJ; Schweizer ML
    J Antimicrob Chemother; 2014 Jul; 69(7):1748-54. PubMed ID: 24633207
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identifying all at-risk patients for Clostridium difficile infection.
    Çoban M; Sertoğlu E
    J Clin Gastroenterol; 2015 Feb; 49(2):172. PubMed ID: 25110874
    [No Abstract]   [Full Text] [Related]  

  • 70. Clostridium difficile outcomes difficult to generalize. Authors' response.
    Zahar JR; Timsit JF
    Crit Care; 2013; 17(1):415. PubMed ID: 25237683
    [No Abstract]   [Full Text] [Related]  

  • 71. Racial and ethnic disparities in health care-associated Clostridium difficile infections in the United States: State of the science.
    Yang S; Rider BB; Baehr A; Ducoffe AR; Hu DJ
    Am J Infect Control; 2016 Jan; 44(1):91-6. PubMed ID: 26454749
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Environmental control critical for controlling Clostridium difficile infections.
    Curtis L
    J Chemother; 2008 Jun; 20(3):385-6; author reply 385-6. PubMed ID: 18606597
    [No Abstract]   [Full Text] [Related]  

  • 74. Reply to Wiegand et al.: proton pump inhibitor over-use and the ongoing battle to control Clostridium difficile infection in hospitals.
    Goyder A; Herbert R
    J Hosp Infect; 2013 Jun; 84(2):188. PubMed ID: 23639818
    [No Abstract]   [Full Text] [Related]  

  • 75. Difficulties with Clostridium difficile.
    Rodney JR; Barie PS
    Surg Infect (Larchmt); 2007 Dec; 8(6):553-6. PubMed ID: 18171113
    [No Abstract]   [Full Text] [Related]  

  • 76. Hospital roommates and development of health care-onset Clostridium difficile infection.
    Echaiz JF; Veras L; Zervos M; Dubberke E; Johnson L
    Am J Infect Control; 2014 Oct; 42(10):1109-11. PubMed ID: 25278404
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Successful measures to combat Clostridium difficile at Herlev Hospital].
    Jarløv JO; Arpi M
    Ugeskr Laeger; 2014 Feb; 176(4):. PubMed ID: 25095863
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chlorhexidine bathing and Clostridium difficile infection in a surgical intensive care unit.
    Bui LN; Swan JT; Shirkey BA; Olsen RJ; Long SW; Graviss EA
    J Surg Res; 2018 Aug; 228():107-111. PubMed ID: 29907198
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Engaging patients in the prevention of health care-associated infections: a survey of patients' awareness, knowledge, and perceptions regarding the risks and consequences of infection with methicillin-resistant Staphylococcus aureus and Clostridium difficile.
    Ottum A; Sethi AK; Jacobs E; Zerbel S; Gaines ME; Safdar N
    Am J Infect Control; 2013 Apr; 41(4):322-6. PubMed ID: 22884494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.